Career history of Carl Bjartmar
Former positions of Carl Bjartmar
| Companies | Position | Start | End |
|---|---|---|---|
| ASCELIA PHARMA AB | Chief Tech/Sci/R&D Officer | 2017-12-31 | 2022-12-30 |
| WILSON THERAPEUTICS AB | Chief Tech/Sci/R&D Officer | 2015-06-30 | 2018-08-31 |
Genzyme AB
 Genzyme AB Pharmaceuticals: MajorHealth Technology Genzyme AB develops and manufactures specialty therapeutic, surgical and diagnostic products. The firm focuses specifically on these areas, has evolved over the years to include immune disorders, cardiovascular diseases, stem cell mobilization and other areas where the lack of adequate treatment. The company was founded in 1981 and is headquartered in Stockholm, Sweden. | Chief Tech/Sci/R&D Officer | - | - |
Sanofi Aventis AB
 Sanofi Aventis AB Sanofi Aventis AB engages in the pharmaceutical industsry. The company is headquartered in Stockholm, Sweden. | Chief Tech/Sci/R&D Officer | - | - |
Training of Carl Bjartmar
| University of Linköping | Doctorate Degree |
Statistics
International
| Sweden | 6 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ASCELIA PHARMA AB | Health Technology |
| Private companies | 3 |
|---|---|
Sanofi Aventis AB
Sanofi Aventis AB Sanofi Aventis AB engages in the pharmaceutical industsry. The company is headquartered in Stockholm, Sweden. | |
Genzyme AB
Genzyme AB Pharmaceuticals: MajorHealth Technology Genzyme AB develops and manufactures specialty therapeutic, surgical and diagnostic products. The firm focuses specifically on these areas, has evolved over the years to include immune disorders, cardiovascular diseases, stem cell mobilization and other areas where the lack of adequate treatment. The company was founded in 1981 and is headquartered in Stockholm, Sweden. | Health Technology |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Wilson Therapeutics AB engages in the development of novel therapies for patients with rare copper-mediated disorders. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden. | Health Technology |
- Stock Market
- Insiders
- Carl Bjartmar
- Experience
